Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8615158234258 |
| E-mail: | 3991135489@qq.com |
| QQ: | 3991135489 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid | C18H21NO2 | 1039307-95-3 | Details |
| ((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester | C20H23NO3 | 149709-58-0 | Details |
| Sacubitril Impurity 7 | C22H25NO5 | 149709-44-4 | Details |
| [1,1′-Biphenyl]-4-pentanoic acid, γ-[[(2E)-3-carboxy-1-oxo-2-propen-1-yl]amino]-α-methyl-, 4-ethyl ester, (αR,γS)- (ACI) | C24H27NO5 | 2984580-03-0 | Details |
| methyl 3-hydroxybicyclo[1.1.1]pentane-1-carboxylate | C7H10O3 | 2092825-26-6 | Details |
| TERT-BUTYL 4-OXOCYCLOHEXANECARBOXYLATE | C11H18O3 | 38446-95-6 | Details |
| C19H19N3O3 | 2407652-86-0 | Details |
| C25H28N6O | 133690-91-2 | Details |
| C19H20N6O3 | 2254485-68-0 | Details |
| C23H27N5O3 | 952652-79-8 | Details |
| C25H31N5O3 | 878559-74-1 | Details |
| C25H31N5O3 | 3036651-86-9 | Details |
| C24H28N2O3 | 443093-86-5 | Details |
| C19H20N2O2 | 1071286-94-6 | Details |
| 2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-carbaldehyde | C14H10N4O | 151052-40-3 | Details |
| (2S)-2-[bis({4-[2-(1H-1,2,3,4-tetrazol-5-yl)biphenyl-methyl)amino]-3-methylbutanoic acid | C33H31N9O2 | 1353844-75-3 | Details |
| C24H29N5O3 | 137862-87-4 | Details |
| C12H14O4 | 2851-82-3 | Details |
| C10H11NO2 | 2510-33-0 | Details |
| 1-[Benzyl-(2-hydroxy-ethyl)-amino]-3-chloro-propan-2-ol | C12H18ClNO2 | 174560-84-0 | Details |
| (S)-2-Oxo-iMidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl este | C16H20N2O5 | 77999-24-7 | Details |
| Ethanol, 2-[(phenylmethyl)amino]-, 1-acetate | C11H15NO2 | 190124-27-7 | Details |
| 2-(2-Ethoxyphenoxymethyl)oxirane | C11H14O3 | 5296-35-5 | Details |
| Acetamide, N,N′-[(1-acetyl-2,3-dihydro-5,5′-dimethoxy[2,6′-bi-1H-indole]-3,3′-diyl)di-2,1-ethanediyl]bis-, trans- (ZCI) | 176244-72-7 | Details |
| (R)-3-Amino-3-(4-chlorophenyl)propan-1-ol | C9H12ClNO | 1213362-28-7 | Details |
| calcium cyclohexane-1,2-dicarboxylate | C8H14CaO4 | 491589-22-1 | Details |
| 1-[Benzyl-(2-hydroxy-ethyl)-amino]-3-(2-ethoxy-phenoxy)-propan-2-ol | C20H27NO4 | 1338700-16-5 | Details |
| 1-Chloro-3-(2-ethoxy-phenoxy)-propan-2-ol | C11H15ClO3 | 42865-09-8 | Details |
| 1-chloro-3-(2-methoxyphenoxy)propan-2-yl acetate | C12H15ClO4 | 141987-28-2 | Details |
| Ethyl 2-chloro-2-(2-(4-chlorophenyl)hydrazono)acetate | C10H10Cl2N2O2 | 27143-09-5 | Details |
| Urapidil N-Oxide | C20H29N5O4 | 1703052-28-1 | Details |
| Cetirizine Ethyl Ester (USP RC A) | C23H29ClN2O3 | 246870-46-2 | Details |
| Suxibuzone | C24H26N2O6 | 27470-51-5 | Details |
| Apixaban Impurity 05-5 | C10H10Cl2N2O2 | 132839-05-5 | Details |
| 4-Benzyl-2-[(2-ethoxyphenoxy)methyl]morpholine | C20H25NO3 | 47374-79-8 | Details |
| 1-(2-Propen-1-yl) hydrogen N-[(2-propen-1-yloxy)carbonyl]-L-glutamate | C12H17NO6 | 91871-28-2 | Details |
| Fmoc-alpha-Me-L-Lys(Alloc)-OH | C26H30N2O6 | 1934266-47-3 | Details |
| 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione | C20H22N2O3 | 23111-33-3 | Details |
| 3-FLUOROTHIOBENZAMIDE | C7H6FNS | 72505-20-5 | Details |
| (S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-5-hydroxypentanoate | C14H27NO5 | 90194-99-3 | Details |
| Fmoc-3-iodo-L-alanine Methyl Ester | C19H18INO4 | 156017-42-4 | Details |
| (3R,4R)-tert-butyl 4-amino-3-hydroxypiperidine-1-carboxylate | C10H20N2O3 | 1007596-95-3 | Details |
| {2-oxabicyclo[2.2.2]octan-4-yl}methanamine | C8H15NO | 2167317-09-9 | Details |
| 5-Oxaspiro[3.4]octan-7-amine | C7H13NO | 1823901-45-6 | Details |
| 2-oxabicyclo[2.2.2]octane-4-carbaldehyde | C8H12O2 | 1212021-23-2 | Details |
| 2-Naphthalenecarboxylic acid, 4-hydroxy-1-methyl-, methyl ester | C13H12O3 | 169682-23-9 | Details |
| 4-[2-(1-PYRROLIDINYL)ETHOXY]-BENZENEACETIC ACID | C14H19NO3 | 714230-90-7 | Details |
| 3-Difluoromethyl-bicyclo[1.1.1]pent-1-ylamine | C6H9F2N | 1886967-47-0 | Details |
| 2-(1-methylimidazol-2-yl)pyridine | C9H9N3 | 77429-59-5 | Details |
| Atorvastatin impurities 163 | C14H15FO3 | 131000-98-1 | Details |
| 2-oxabicyclo[2.2.2]octane-4-carboxylic acid | C8H12O3 | 2168906-49-6 | Details |
| N-Alloc-L-Glutamic acid 5-tert-butyl ester | C13H21NO6 | 192753-43-8 | Details |
| (E)-Ethyl 3-(4-methylphenyl)prop-2-enoate | C12H14O2 | 24393-49-5 | Details |
| Lizatriptan impurity 27 sodium salt | C9H9N5O3S.Na | 3023103-42-3 | Details |
| Lizatriptan impurity 27 | C9H9N5O3S | 3023103-41-2 | Details |
| Lizatriptan impurity 28 | C9H11N5O3S.Na | 3023103-46-7 | Details |
| 4-(bromomethyl)-2-oxabicyclo[2.2.2]octane | C8H13BrO | 2413898-31-2 | Details |
| (2-oxabicyclo[2.2.2]octan-4-yl)methanamine hydrochloride | C8H16ClNO | 2173991-83-6 | Details |
| 2-Oxabicyclo[2.2.2]Octan-4-amine | C7H13NO | 2166968-08-5 | Details |
| 2-Oxabicyclo[2.1.1]hexan-1-ylmethanol | C6H10O2 | 2060007-65-8 | Details |
| 2-Oxabicyclo[2.1.1]hexan-4-ylmethanol | C6H10O2 | 1782594-07-3 | Details |
| 1-methoxycarbonyl-2-oxabicyclo[2.2.2]octane-4-carboxylicacid | C10H14O5 | 1801203-48-4 | Details |
| (R)-(3-Methyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride | C10H21ClN2O2 | 2222683-65-8 | Details |
| Ethyl 4-bromomethylcinnamate | C12H13BrO2 | 60682-98-6 | Details |
| 4-(4-Chlorobutoxy)butan-1-ol | C8H17ClO2 | 60767-73-9 | Details |
| Details |
| C17H26N2O2 | 1027600-42-5 | Details |
| C8H13N3O5S | 52455-84-2 | Details |
| 2-(3-methyl-2-oxopyrrolidin-1-yl)acetamide | C7H12N2O2 | 33996-49-5 | Details |
| C20H28O5 | 511-25-1 | Details |
| C11H15NO3 | 21809-05-2 | Details |
| 2-oxo-5,5-diphenyltetrahydro-4-furancarboxylic acid | C17H14O4 | 79371-39-4 | Details |
| 2-(hydroxymethyl)-1,1-diphenylbutane-1,4-diol | C17H20O3 | 93727-70-9 | Details |
| Citalopram Impurity 16 | C21H15F2NO2 | 762266-07-9 | Details |
| 2-(2-Allyloxy-phenoxymethyl)-oxirane | C12H14O3 | 6452-72-8 | Details |
| 1H-Indole-1,3-dicarboxylic acid, octahydro-, 1-(9H-fluoren-9-ylmethyl) ester | C24H25NO4 | 2913424-91-4 | Details |
| Citalopram Impurity 86 | C40H39FN2O9 | 2173043-07-5 | Details |
| Citalopram Impurity 85 | C40H39FN2O9 | 2173043-05-3 | Details |
| Triclosan Impurity 7 | C10H8Cl2O2 | 134479-47-3 | Details |
| Escitalopram Impurity 12 | C20H25FN2O3 | 658080-71-8 | Details |
| Tolvaptan dehydration impurity | C26H23ClN2O2 | 176970-21-1 | Details |
| [2-[2-(Diphenylphosphino) phenoxy] phenyl] diphenyl phosphine oxide | C36H28O2P2 | 871130-32-4 | Details |
| (S)-2-(((9H-fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid | C25H21NO4 | 2322924-83-2 | Details |
| 2,4,6-Trimethoxyphenol | C9H12O4 | 20491-92-3 | Details |
| N-Methoxy-N-Nitroso-Methanamine | C2H6N2O2 | 16339-12-1 | Details |
| 1-(1-benzothiophen -4-yl)-4-nitrosopiperzine | C12H13N3OS | 2639426-95-0 | Details |
| 6-hydroxy-2-(2-(4'-methoxyphenyl)ethyl)chromone | C18H16O4 | 125092-36-6 | Details |
| Ataluren Impurity 7 | C16H13FN2O4 | 775304-80-8 | Details |
| Details |
| Details |
| C11H9ClN2O | 24155-32-6 | Details |
| C8H4BrCl3O | 56719-70-1 | Details |
| Acyclovir Impurity 3 | C9H16O6 | 21912-27-6 | Details |
| Sulconazle Impurity 10; 2-(1H-imidazol-1-yl)-1-phenylethanone | C11H10N2O | 24155-34-8 | Details |
| C11H9ClN2O | 27087-94-1 | Details |
| C10H11Cl2NOS | 1165796-81-5 | Details |
| 2-(3,4,5-trihydroxyphenoxy)benzene-1,3,5-triol | C12H10O7 | 53254-99-2 | Details |
| CYCLOPROPYLMETHANOL ACETATE | C6H10O2 | 36982-54-4 | Details |
| Sacubitril Impurity 12 | C23H27NO4 | 1015037-46-3 | Details |
| N-Nitroso N-Desmethyl-Galantamine | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||